S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
NASDAQ:QNRX

Quoin Pharmaceuticals - QNRX Institutional Ownership

$5.10
-0.49 (-8.77%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$4.80
$5.81
50-Day Range
$3.85
$19.80
52-Week Range
$3.58
$444.00
Volume
2.22 million shs
Average Volume
601,670 shs
Market Capitalization
$4.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.00

Institutional Ownership Changes (13F Filings) for Quoin Pharmaceuticals (NASDAQ:QNRX)

Current
Institutional Ownership
Percentage
21.72%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$709,305.63
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$548,392.25
Get QNRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Quoin Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Quoin Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2022Virtu Financial LLC42,665$57K0.0%N/A0.509%
5/13/2022Renaissance Technologies LLC50,400$67K0.0%-39.6%0.601%
(Data available from 1/1/2016 forward)













QNRX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of QNRX shares?

During the previous two years, the following institutional investors and hedge funds held shares of Quoin Pharmaceuticals shares: Renaissance Technologies LLC ($67K), Virtu Financial LLC ($57K).Learn more on QNRX's institutional investors.

What percentage of Quoin Pharmaceuticals stock is owned by institutional investors?

21.72% of Quoin Pharmaceuticals stock is owned by institutional investors. Learn more on QNRX's institutional investor holdings.

Which institutional investors have been buying Quoin Pharmaceuticals stock?

The following institutional investors have purchased Quoin Pharmaceuticals stock in the last 24 months: Virtu Financial LLC ($42.67K).

How much institutional buying is happening at Quoin Pharmaceuticals?

Institutional investors have bought a total of 42,665 shares in the last 24 months. This purchase volume represents approximately $0.71M in transactions.

Which Quoin Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold Quoin Pharmaceuticals stock in the last 24 months: Renaissance Technologies LLC ($32.99K).

How much institutional selling is happening at Quoin Pharmaceuticals?

Institutional investors have sold a total of 32,986 shares in the last 24 months. This volume of shares sold represents approximately $0.55M in transactions.

This page (NASDAQ:QNRX) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.